ASX:COH Cochlear (COH) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.21%Price TargetN/A Stock AnalysisStock Analysis Get Cochlear alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About Cochlear Stock (ASX:COH)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> COH Stock News HeadlinesJuly 24 at 8:22 AM | msn.comShares vs. property: Why it pays to be patientMay 26, 2024 | msn.comHow you could retire rich by investing like Warren BuffettJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...May 1, 2024 | finance.yahoo.comCochlear Limited (COH.AX)April 19, 2024 | finance.yahoo.comCochlear receives FDA clearance to lower the age for the Osia System to 5-years-oldApril 2, 2024 | fxstreet.comCochlear Limited Elliott Wave technical forecast [Video]March 25, 2024 | finance.yahoo.comInvesting in Cochlear (ASX:COH) five years ago would have delivered you a 104% gainMarch 21, 2024 | markets.businessinsider.comCochlear Limited (CHEOF) Gets a Sell from Morgan StanleyJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...March 8, 2024 | finance.yahoo.comShould You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?February 19, 2024 | markets.businessinsider.comHere’s Why Cochlear (COH) Shares Fell Despite Robust ProfitsFebruary 19, 2024 | msn.comASX Large Caps: Property stocks smashed after Lendlease-led rout, a2 Milk soars on solid guidanceFebruary 18, 2024 | msn.comASX 200 opens 0.1% higher; Westpac, Cochlear, Ampol report earningsFebruary 11, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Cochlear Limited (OtherCHEOF) and Demant (OtherWILLF)February 8, 2024 | markets.businessinsider.comHere’s Why Cochlear (COH) Shares Rose TodayFebruary 7, 2024 | msn.comASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemiaFebruary 7, 2024 | msn.comClosing Bell: Interest rates the only thing steady about local markets on TuesdayFebruary 5, 2024 | fool.com.auWhy is the Cochlear share price tumbling 5% on Tuesday?See More Headlines Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CUSIPN/A CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$5.32 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$350.40 million Net Margins16.30% Pretax MarginN/A Return on Equity20.04% Return on Assets11.80% Debt Debt-to-Equity Ratio11.60 Current Ratio2.57 Quick Ratio1.93 Sales & Book Value Annual Sales$2.15 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$27.17 per share Price / BookN/AMiscellaneous Outstanding Shares65,490,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.46 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $4.78MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $2.04MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsRob McGroryGroup General CounselMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersDig HowittSold 279 sharesTotal: $60,621.12 ($217.28/share)Michael del PradoBought 117 shares on 11/14/2023Total: $19,798.04 ($169.21/share)Karen PenroseBought 138 shares on 10/18/2023Total: $34,885.99 ($252.80/share)Dig HowittSold 3,622 sharesTotal: $936,431.88 ($258.54/share)Karen PenroseBought 130 shares on 9/5/2023Total: $34,805.94 ($267.74/share) COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) announced its quarterly earnings data on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a net margin of 16.30% and a trailing twelve-month return on equity of 20.04%. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include iShares Core S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT) and Afterpay (APT). This page (ASX:COH) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
